Cited by 167Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder ResearchPI3K/AKT/mTOR signaling in cancer

Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism

Open access
Huber, Kimberly M., Klann, Eric, Costa-Mattioli, Mauro, Zukin, R. Suzanne·2015·The Journal of Neuroscience

Abstract

The mammalian target of rapamycin (mTOR) is a central regulator of a diverse array of cellular processes, including cell growth, proliferation, autophagy, translation, and actin polymerization. Components of the mTOR cascade are present at synapses and influence synaptic plasticity and spine morphogenesis. A prevailing view is that the study of mTOR and its role in autism spectrum disorders (ASDs) will elucidate the molecular mechanisms by which mTOR regulates neuronal function under physiological and pathological conditions. Although many ASDs arise as a result of mutations in genes with multiple molecular functions, they appear to converge on common biological pathways that give rise to autism-relevant behaviors. Dysregulation of mTOR signaling has been identified as a phenotypic feature common to fragile X syndrome, tuberous sclerosis complex 1 and 2, neurofibromatosis 1, phosphatase and tensin homolog, and potentially Rett syndrome. Below are a summary of topics covered in a symposium that presents dysregulation of mTOR as a unifying theme in a subset of ASDs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.2656-15.2015

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Huber, K. M., Klann, E., Costa-Mattioli, M., & Zukin, R. S.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • New York University (US)
  • Albert Einstein College of Medicine (US)
Venue
The Journal of Neuroscience
Published
2015-10-14
Volume
35
Issue
41
Pages
13836-13842
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2176535580
Cited by
167
References
51
Citations by year
2026: 4 · 2025: 6 · 2024: 10 · 2023: 15 · 2022: 22 · 2021: 18 · 2020: 16 · 2019: 19 · 2018: 25 · 2017: 22 · 2016: 10
FWCI
12.98
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Mental Health (R01MH096816)
  • National Institute of Neurological Disorders and Stroke (R01NS045711, R01NS047384, R01NS076708)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
mTOR signaling, autism spectrum disorder, fragile X syndrome, tuberous sclerosis complex, neurofibromatosis type 1, PTEN, Rett syndrome, synaptic plasticity, autophagy, mouse models of autism
MeSH terms
Animals, Autistic Disorder, Disease Models, Animal, Humans, Models, Biological, Signal Transduction, Sirolimus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review